Erection-inducing methods and compositions

Details Erection-inducing methods and compositions Erection-inducing methods and compositions

1989-09-18

1993-08-17

Cashion, Jr., Merrell C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530324, A61K 3700, A61K 3702, C07K 500, C07K 400

Patent

active

052369048

ABSTRACT:
The present invention provides methods and compositions for inducing penile erections, sufficient for vaginal penetration, in a human male suffering from impotence. When the impotence is substantially only neurogenic, psycogenic or neurogenic and psychogenic, a method of the invention comprises (A) administering to the male by intracavernosal injection peptide N-terminal histidine C-terminal methionineamide and (B) sexually stimulating the male. When the impotence is caused by severe atherosclerosis, a method of the invention comprises (A) administering to the male by intracavernosal injection an amount of a physiologically acceptable composition comprising (1) a neuropeptide selected from the group consisting of human vasoactive intestinal peptide and peptide N-terminal histidine C-terminal methionineamide and (2) an alpha-adrenergic blocker, such as phentolamine or prazosin, and (B) sexually stimulating the male. The invention also entails a physiologically acceptable composition suitable for use in inducing, upon administration by intracavernosal injection, an erection, sufficient for vaginal penetration, in a human male suffering from impotence, which is caused by severe atherosclerosis, which composition comprises (1) a neuropeptide selected from the group consisting of vasoactive intestinal peptide and peptide N-terminal histidine C-terminal methionineamide and (2) an alpha-adrenergic blocker, such as phentolamine or prazosin.

REFERENCES:
patent: 3898329 (1975-08-01), Said et al.
patent: 4757133 (1988-06-01), Ito et al.
patent: 4939224 (1990-03-01), Musso et al.
Polak et al., Peptides, vol. 5, 1984 pp. 225-230.
Bodner et al., PNAS, vol. 82, 1985, pp. 3548-3551.
Willis et al., Chemical Abstracts, vol. 96, 1982, No. 4180p.
Kiely et al., Biological Abstracts, vol. 88, 1989, No. 123539.
Ottesen et al., Chemical Abstracts, vol. 100, 1984, No. 97098g.
Fahrenkrug et al., Annals of New York Academy of Sciences, vol. 527, 1988, pp. 393-404.
Ottesen, et al., "Vasoactive intestinal polypeptide (VIP) increases vaginal blood flow and inhibits uterine smooth muscle activity in women," Euro. Journal of Clinical Investigation 13:321-324 (1983).
Wagner, et al., "Intracavernosal injection of vascoactive intestinal polypeptide (VIP) does not induce erection in man per se," World Journal Urol., 5:171-172 (1987).
Kiely, et al., "Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents," British Journal of Urology, 64:191-194 (1989).
Brindley, "Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence," British Journal Psychiat. 143:332-337 (1983).
Willis, et al., "Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection," Life Sciences, 33:383-391 (1983).
Ottesen, et al., "Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter," British Medical Journal, 288:9-11 (1984).
Adaikan, et al., "Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection?" The Journal of Urology, 135:638-640 (1986).
Itoh, et al., "Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27," Nature, 304:547-549 (1983).
Weiner, "Drugs that inhibit adrenergic nerves and block adrenergic receptors", in Goodman and Gilman, eds., The Pharmacological Basis of Therapeutics, MacMillan Publishing Co., New York, N.Y., 6th Ed., Chapter 9:176-210 (1980).

Affiliated with

Also associated with

Rating

Erection-inducing methods and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erection-inducing methods and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erection-inducing methods and compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2243790